The Manila Times6h
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
Scientific publications and reach in the field have shown already that post-injury angiogenesis and vascular remodeling ...
Preclinical study demonstrates improved gene therapy approach to treating a rare and devastating disease in children
In a preclinical study, researchers at Children's Hospital of Philadelphia (CHOP) demonstrated a novel gene therapy with ...
Preclinical study finds earlier ACL reconstruction is associated with lower risk of knee osteoarthritis
A preclinical study by HSS investigators found that earlier anterior cruciate ligament (ACL) reconstruction led to lower ...
1MIRA : EXCLUSIVE: MIRA Pharmaceuticals Expands Pipeline, Enhances Value Proposition...
MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...
The Manila Times4d
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
Polyrizon Ltd. (Nasdaq: PLRZ) (the 'Company' or 'Polyrizon'), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced today the initiation of ...
Morningstar2d
Hospital for Special Surgery Preclinical Study Finds Earlier ACL Reconstruction is Associated with Lower Risk of Knee Osteoarthritis
A preclinical study by HSS (Hospital for Special Surgery) investigators found that earlier anterior cruciate ligament (ACL) reconstruction led to lower immune cell activity, less inflammation and ...
EurekAlert!3d
Preclinical study finds earlier ACL reconstruction is associated with lower risk of knee osteoarthritis
A preclinical study by HSS investigators found that earlier anterior cruciate ligament (ACL) reconstruction led to lower immune cell activity, less inflammation and fewer joint changes associated ...
Morningstar4d
Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform
These preclinical studies mark a step forward in evaluating Polyrizon’s Trap and Target™ (T&T) platform for the intranasal administration of Naloxone, an opioid antagonist designed to rapidly ...
Becker's Spine Review6h
9 recent spine, orthopedic studies to know
From findings about GLP-1s to spine surgery costs, Becker’s reported on nine key studies in spine and orthopedics since Feb. 13. 1. A study of cervical disc replacements in The Spine Journal found ...
MIRA Pharmaceuticals Expands Ketamir-2 Development with Topical Treatment for Localized Neuropathic and Inflammatory Pain
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...
Nasdaq4d
Polyrizon Ltd. Initiates Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdoses
Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the start of preclinical studies for its intranasal Naloxone product aimed at treating opioid overdoses. Collaborating ...
Investing4d
Polyrizon begins preclinical studies for nasal opioid overdose treatment
RAANANA, Israel - Polyrizon Ltd. (NASDAQ:PLRZ), a micro-cap biotech firm with a market capitalization of $3.46 million focused on developing nasal hydrogels, has launched preclinical studies for ...